Biotechnology Stocks
| # | Son 7 Gün | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2477 | ARDX Ardelyx, Inc. - Common Stock | 3.80 USD | -2.31% | -5.71% | -25.93% | -38.11% | 946.91 M USD | ||
| 2490 | ANNX Annexon, Inc. - common stock | 4.84 USD | -4.54% | -4.91% | -8.68% | +110.43% | 917.56 M USD | ||
| 2508 | DSGN Design Therapeutics, Inc. - Common Stock | 15.01 USD | +0.13% | +1.90% | +16.72% | +186.45% | 939.35 M USD | ||
| 2510 | OLMA Olema Pharmaceuticals, Inc. - Common Stock | 10.40 USD | -2.71% | -2.26% | -13.19% | +26.98% | 909.98 M USD | ||
| 2531 | IVA Inventiva S.A. - American Depository Shares | 4.64 USD | -0.85% | -0.43% | +4.50% | -2.73% | 896.62 M USD | ||
| 2547 | TBPH Theravance Biopharma, Inc. - Ordinary Shares | 17.01 USD | 0.00% | +0.29% | +0.83% | +18.54% | 883.14 M USD | ||
| 2558 | FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 14.64 USD | -7.52% | +9.25% | +43.25% | +29.56% | 808.78 M USD | ||
| 2577 | DBVT DBV Technologies S.A. - American Depositary Shares | 14.01 USD | -3.71% | -4.04% | +1.89% | +42.81% | 829.56 M USD | ||
| 2579 | RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 45.05 USD | -1.83% | +5.38% | +20.78% | +49.52% | 841.53 M USD | ||
| 2602 | PHAR Pharming Group N.V. - ADS, each representing 10 | 11.51 USD | -2.21% | -3.92% | -11.12% | -19.28% | 807.63 M USD | ||
| 2606 | ACHV Achieve Life Sciences, Inc. - Common Shares | 7.72 USD | -3.38% | +4.61% | +24.92% | +144.30% | 794.41 M USD | ||
| 2621 | AURA Aura Biosciences, Inc. - Common Stock | 7.61 USD | -2.44% | -1.04% | +7.18% | +16.36% | 789.19 M USD | ||
| 2652 | NGNE Neurogene Inc. - Common Stock | 38.09 USD | -1.40% | +5.10% | +8.83% | +29.47% | 762.23 M USD | ||
| 2656 | GYRE Gyre Therapeutics, Inc. - Common Stock | 6.86 USD | -0.72% | +3.63% | +14.14% | -16.95% | 764.96 M USD | ||
| 2657 | NVCT Nuvectis Pharma, Inc. - Common Stock | 23.47 USD | -0.38% | +23.27% | +21.17% | +240.64% | 764.69 M USD | ||
| 2667 | STTK Shattuck Labs, Inc. - Common Stock | 7.73 USD | +2.66% | +5.03% | +4.88% | +731.18% | 775.81 M USD | ||
| 2680 | TECX Tectonic Therapeutic, Inc. - Common Stock | 36.05 USD | -4.20% | +4.22% | +18.08% | +110.20% | 704.75 M USD | ||
| 2685 | BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.08 USD | 0.00% | +0.44% | +0.89% | +0.22% | 727.98 M USD | ||
| 2688 | MNPR Monopar Therapeutics Inc. - Common Stock | 106.13 USD | -1.48% | -8.31% | -3.77% | +94.31% | 712.36 M USD | ||
| 2691 | ALLO Allogene Therapeutics, Inc. - Common Stock | 2.02 USD | -3.35% | -1.46% | +12.22% | +66.94% | 697.89 M USD |
Haberler Biotechnology Stocks
Deutsche Bank, argenx hissesini değerleme nedeniyle Tut’a düşürdü
Monte Rosa Therapeutics hissesi neden düşüyor?
Biomea Fusion hisseleri diyabet çalışması kayıt tamamlanmasıyla yükseldi
Monte Rosa hisseleri faz 2 prostat kanseri çalışması başlarken düştü
H.C. Wainwright, Biomea Fusion hissesi için hedef fiyatı korudu
Crinetics Pharmaceuticals hissesi 84,8 dolarda zirve yaptı
FDA, Capricor’un deramiocel incelemesini 22 Kasım’a uzattı
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |